Key result
Cardiac sarcoid was identified in 15% of patients with suspected ARVD/C, and left ventricular dysfunction was the only clinical feature discriminating sarcoid (100%) from ARVD/C (11.8%; P=0.01).
Why the study?
What is the incidence and what are the clinical predictors of cardiac sarcoid in patients with suspected ARVD/C?
Observational (n=20)
What is the incidence and what are the clinical predictors of cardiac sarcoid in patients with suspected ARVD/C?
Cardiac sarcoidosis can mimic ARVD/C in a significant proportion of patients (15%), and left ventricular dysfunction is a key clinical feature distinguishing sarcoid from ARVD/C.
LV dysfunction may prompt sarcoid evaluation in suspected ARVD/C; leaves open need for prospective validation of predictors.
INTRODUCTION: Case studies indicate that cardiac sarcoid may mimic the clinical presentation of arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C); however, the incidence and clinical predictors to diagnose cardiac sarcoid in patients who meet International Task Force criteria for ARVD/C are unknown. METHODS AND RESULTS: Patients referred for evaluation of left bundle branch block (LBBB)-type ventricular arrhythmia and suspected ARVD/C were prospectively evaluated by a standardized protocol including right ventricle (RV) cineangiography-guided myocardial biopsy. Sixteen patients had definite ARVD/C and four had probable ARVD/C. Three patients were found to have noncaseating granulomas on biopsy consistent with sarcoid. Age, systemic symptoms, findings on chest X-ray or magnetic resonance imaging (MRI), type of ventricular arrhythmia, RV function, ECG abnormalities, and the presence or duration of late potentials did not discriminate between sarcoid and ARVD/C. Left ventricular dysfunction (ejection fraction <50%) was present in 3/3 patients with cardiac sarcoid, but only 2/17 remaining patients with definite or probable ARVD/C (P = 0.01). CONCLUSIONS: In this prospective study of consecutive patients with suspected ARVD/C evaluated by a standard protocol including biopsy, the incidence of cardiac sarcoid was surprisingly high (15%). Clinical features, with the exception of left ventricular dysfunction and histological findings, did not discriminate between the two entities.
No takes yet. Share an insight, caveat, or question.
Vasaiwala et al. (2008) conducted an observational in Suspected arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) (n=20). Right ventricle cineangiography-guided myocardial biopsy vs. Clinical evaluation without sarcoidosis was evaluated on Left ventricular dysfunction (ejection fraction <50%) (p=0.01). Cardiac sarcoid was identified in 15% of patients with suspected ARVD/C, and left ventricular dysfunction was the only clinical feature discriminating sarcoid (100%) from ARVD/C (11.8%; P=0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: